“The best thing I’ve ever done for myself.”

Gold Ridge Fire Chief Shepley Schroth-Cary (pictured here receiving IV glutathione at one of our wellness clinics) has funded his firefighters’ participation in both rounds of the Firefighter Detoxification Pilot Program and participated himself.

Firefighter Detoxification Pilot Program

Our partner physicians know from years of experience that inhalable and intravenous glutathione can help firefighters reduce their chemical burdens, heal chronic coughs, and reverse liver disease, but we’re determined to find out just how effective it can be.

No one has researched glutathione’s ability to detox firefighters – until now.

Along with Integrative Healers Action Network and Wild Oak Medicine, the Volunteer Fire Foundation has administrated two rounds of this groundbreaking study based in Sonoma County, California.

The Protocol:

• Intravenous glutathione – mobilizes toxins, supports detoxification pathways, heals liver tissue

• Nebulized glutathione – expectorates toxins and foreign matter from lungs, heals lung tissue

• Liposomal glutathione – supports detox and cellular function

• Supplements – support detoxification and liver function

• Sauna – helps to excrete mobilized toxins through sweat

• Massage – supports detoxification by improving circulation and lymphatic flow

Results

Round 1 (2023):

Duration: 16 weeks

Participants: ten firefighters (a mix of full-time and volunteers) from three local agencies

Testing: doctors ran full metabolic panels and three toxicology panels (before treatment, halfway through, and immediately after completion). Toxicology panels tested for 103 toxins including heavy metals, petrochemicals, mold toxins, environmental chemicals, and PFAS chemicals.

Key takeaways

  • The total number of high-range (95th percentile) toxins across all participants decreased 72.5%

  • Glyphosate was among the top three most prevalent toxins, with many participants showing levels 2-3 times the 95th percentile. By the end of treatment, glyphosate levels decreased 93% 

  • Participants’ PFAS levels shifted slightly during Round 1 treatment, indicating that it may be possible to mobilize these chemicals – and if we can mobilize them, we may be able to reduce or even eliminate them. (SEE BELOW FOR UPDATE)

Early results from the second round are even more compelling

(We are still awaiting final test results from two participants. The data below is preliminary and will be updated as soon as possible.)

Round 2 (2024)

Duration: 16 weeks

Participants: eleven firefighters (a mix of full-time and volunteers) from two local agencies

Testing: Same as Round 1

Key takeaways

  • The total number of high-range (95th percentile) toxins across all participants decreased 81.4%

  • The total number of high-range mycotoxins (molds) decreased 86.7%

  • The total number of high-range environmental toxins decreased 85.1%

  • The total number of high-range environmental toxins decreased 85.1%

Case studies from Round 2

Case study #1

Participant started with 16 toxins in the 95th percentile and 17 toxins in the 75th. After treatment, he had two toxins in the 95th – an 87.5% decrease – and 11 toxins in the 75th. Within two months of starting treatment, he reported that an occupational ultrasound revealed that his chronic liver disease was no longer detectable.

To learn more about this case study, click here or download the PDF below.

Case study #2

Participant 2 started with four toxins in the 95th percentile and eight in the 75th. After treatment, he had zero toxins in the 95th percentile – a 100% decrease and six in the 75th. Within two months of starting treatment, he reported that an occupational ultrasound revealed that his chronic liver disease was no longer detectable.

To learn more about this case study, download the PDF below.

A few notes on the protocol:

Very little In 2016, the Association of American Medical Colleges (AAMC) reported that While unfamiliar to Allopathic physicians,

https://www.aamc.org/news/experts-see-growing-importance-adding-environmental-health-content-medical-school-curricula

If the California Board of Pharmacy eliminates access to sterile-compounded glutathione, there is no relacement.

What’s motivating the California BOP?

We don’t know.

We’ve spoken with physicians, lawyers, pharmacists, and pharmacy experts across the United States and no one seems to understand what’s motivating the BOP’s extreme stance – but it’s not just glutathione they’re after.

Over the past few years, the California Board of Pharmacy has waged war against sterile compounding pharmacy itself, filing eight lawsuits against reputable sterile compounding pharmacies.

The lawsuits challenge pharmacists’ right to dispense FDA Category 1 substances (not to be confused with Schedule I controlled substances), including glutathione, methylcobalamin (vitamin B12), various peptides and other substances.

The Board has lost all eight lawsuits but that hasn’t stopped its executive staff from seeking to eliminate our access to these lifesaving and life-changing medications.

The FDA has deemed glutathione to be safe. There is no scientific or medical reason why we shouldn’t have access.

We need your help to #stopthebop.

Here’s what you can do:

  1. Sign and share this petition.

    Bonus points if you specify that you’re a firefighter. (If you’re a member of a local, share that too.)

  2. Learn more.

    Explore the resources below or email VFF executive director Jacqui Jorgeson at jacqui@volunteerfire.org.

  3. Spread the word.

    Tell your firefighter brothers and sisters. Tell your chief. Tell your union reps. Tell everyone because the impact of this vote extends far beyond the fire service.